Methotrexate from China
Methotrexate is a folic acid antagonist containing pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. Classified under HTS 2934.99.4700 as a pharmaceutical drug with 'other heterocyclic compounds' structure. Its complex ring system with multiple nitrogens defines its Chapter 29 placement.
Duty Rate — China → United States
112.5%
Rate breakdown
9903.04.6096.3%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.3112.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of China, as provided for in U.S. note 52 to this subchapter
Import Tips
• Submit FDA IND/NDA documentation for API import; maintain GMP-certified supply chain; beware reclassification risk if purity <99% suggesting intermediate status